Inhibition by cholesterol oxides of NO release from human vascular endothelial cells

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 7, 1998, Pages 1054-1060

  Deckert, Valérie ^b   Brunet, Annie ^a   Lantoine, Frédérique ^a   Lizard, Gérard ^b   Millanvoye van Brussel, Elisabeth ^a   Monier, Serge ^b   Lagrost, Laurent ^b   David Dufilho, Monique ^a   Gambert, Philippe ^b   Devynck, Marie Aude ^a  

^a Laboratoire de Pharmacologie CNRS URA 1482   (France)

^b INSERM   (France)

Author keywords

Cholesterol oxides; Histamine; Human endothelial cells; NO production

Indexed keywords

7 OXOCHOLESTEROL; ARGININE; CHOLESTEROL DERIVATIVE; HISTAMINE; LYSOPHOSPHATIDYLCHOLINE; NITRIC OXIDE; OXIDE;

AMPEROMETRY; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; LIPID OXIDATION; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 17344366769     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.7.1054     Document Type: Article

References (20)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
2. Shepherd JT, Katusic ZS. Endothelium-derived vasoactive factors, I: endothelium-dependent relaxation. Hypertension. 1991;18(suppl III):III-76-III-85.
3. Vanhoutte PM, Lüscher TF, Gräser T. Endothelium-dependent contractions. Blood Vessels. 1991;28:74-83.
4. Van de Voorde J, Leusen I. Role of the endothelium in the vasodilator response of rat thoracic aorta to histamine. Eur J Parmacol. 1983;87:113-120.
5. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327:524-526.
6. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 1987;84:9265-9269.
7. Tanner FC, Boulanger CM, Lüscher TF. Endothelium-derived nitric oxide, endothelin, and platelet vessel wall interaction: alterations in hypercholesterolemia and atherosclerosis. In: Thieme Medical Publishers, ed. Seminars in Thrombosis and Hemostasis. New York, NY: Thieme Medical Publishers; 1993;19:167-175.
8. Lüscher TF, Boulanger CM, Yang Z, Noll G, Dohi Y. Interactions between endothelium-derived relaxing and contracting factors in health and cardiovascular disease. Circulation. 1993;87(suppl V):V-36-V-44.
9. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995;38:105-128.
10. Busse R, Fleming I. Endothelial dysfunction in atherosclerosis. J Vasc Res. 1996;33:181-194.
11. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, Loscalzo J, Dzau VJ. Impaired vasodilatation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest. 1990;86:228-234.
12. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
13. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest. 1990;86:75-79.
14. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature. 1990;344:160-162.
15. Yokoyama M, Hirata K-I, Miyake R, Akita H, Ishikawa Y, Fukuzaki H. Lysophosphatidylcholine: essential role in the inhibition of endothelium-dependent vasorelaxation by oxidized low density lipoprotein. Biochem Biophys Res Commun. 1990;168:301-308.
16. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries: role of scavenger receptor and endothelium-derived nitric oxide. Circulation. 1991;83:2012-2020.
17. Mangin EL, Kugiyama K, Nguy JH, Kerns SA, Henry PD. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 1993;72:161-166.
18. Plane F, Bruckdorfer RK, Kerr P, Steuer A, Jacobs M. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta. Br J Pharmacol. 1992;105:216-222.
19. Deckert V, Persegol L, Viens L, Lizard G, Athias A, Lallemant C, Gambert P, Lagrost L. Inhibitors of arterial relaxation among components of human oxidized low-density lipoproteins: cholesterol derivatives oxidized in position 7 are potent inhibitors of endothelium-dependent relaxation. Circulation. 1997;95:723-731.
20. Lizard G, Deckert V, Dubrez L, Moisant M, Gambert P, Lagrost L. Induction of apoptosis in endothelial cells treated with cholesterol oxides. Am J Pathol. 1996;148:1625-1638.